From evidence to impact
Epidemiology—and turning research findings into policy—are both key to improving public health, says German health minister Karl Lauterbach at Cutter Lecture.
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2022/12/Karl-Lauterbach_1200x800.jpg)
Preparing for the next pandemic
Karl Lauterbach, Germany’s federal minister of health, discussed the G7 Pact for Pandemic Readiness at a Harvard Chan School seminar.
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2022/07/Karl_-Lauterbach_seminar_1200x800.jpg)
Karl Lauterbach is Germany’s new health minister
Karl Lauterbach, an adjunct faculty member and alumnus of Harvard T.H. Chan School of Public Health, was sworn in as Germany’s health minister on December 8, 2021.
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2020/06/The-Washington-Post-WaPo-logo-feature.jpg)
German model for drug price regulation may be good for U.S.
A five-year-old drug price regulatory system in Germany may be a good model for the U.S. to consider to tackle its own problem with unaffordable prescription drug prices, according to experts from Harvard T.H. Chan School of Public…